We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CNTX market cap is 30.97M. The company's latest EPS is USD -1.5009 and P/E is -1.29.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.67M | -5.29M | -6.18M | -6.93M | -3.82M |
| Net Income | -6.31M | -5.01M | -5.87M | -6.77M | -3.67M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -10.53M | -15.88M | -25.07M |
| Net Income | -10.46M | -15.34M | -23.96M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 31.97M | 27.76M | 22.99M | 16.06M | 11.05M |
| Total Liabilities | 3.23M | 3.76M | 4.6M | 4.19M | 2.61M |
| Total Equity | 28.73M | 24.01M | 18.39M | 11.87M | 8.44M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 51.31M | 37.97M | 16.06M |
| Total Liabilities | 3.03M | 3.21M | 4.19M |
| Total Equity | 48.27M | 34.76M | 11.87M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -5.73M | -10.36M | -13.82M | -21.05M | -4.36M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.8M | -13.55M | -21.05M |
| Investing | -250k | -537k | N/A |
| Financing | 58.39M | -102k | N/A |
| Market Cap | 30.97M |
| Price to Earnings Ratio | -1.29 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.14 |
| Price to Book Ratio | 2.61 |
| Dividend Yield | - |
| Shares Outstanding | 15.97M |
| Average Volume (1 week) | 214.21k |
| Average Volume (1 Month) | 175.91k |
| 52 Week Change | 50.39% |
| 52 Week High | 2.24 |
| 52 Week Low | 0.77 |
| Spread (Intraday) | 0.33 (14.8%) |
| Company Name | Context Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.contexttherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
